More about Fortis Healthcare Limited
Fundamentals for Fortis Healthcare Limited
Regulatory Filings for Fortis Healthcare Limited
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
Fundamentals for Fortis Healthcare Limited
|fundrankingplaceholder|
|techrankingplaceholder|
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was founded in 1995 and is based in Gurugram, India.
Revenue projections:
Investors may be wary of FORTIS as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.
Financial Ratios:
| currentRatio | 0.860000 |
|---|---|
| forwardPE | 41.167053 |
| debtToEquity | 34.150000 |
| earningsGrowth | 0.443000 |
| revenueGrowth | 0.178000 |
| grossMargins | 0.415510 |
| operatingMargins | 0.173540 |
| trailingEps | 13.780000 |
| forwardEps | 23.479940 |
With both earnings and revenue growth showing positive trends, FORTIS is expected to expand its business. This signals a healthy financial trajectory, suggesting that the company is positioned for continued growth and increasing profitability.
FORTIS's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with FORTIS anticipated to deliver better earnings than it did in the prior year.
Price projections:
The price of FORTIS has consistently been close to the lower limit of expectations. This trend may point to challenges in the company's performance, leading to concerns about its future growth potential.
Recommendation changes over time:
Analysts have maintained a buy bias for FORTIS, which could prompt investors to consider the stock as a viable investment. With this positive outlook, FORTIS is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
How Independent Directors Failed Rs 2,500 Crore in Value
India’s Stock Market May Be Sitting on a Trap